课题基金 / 基金详情

NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology

NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology
NIAID- VRC - PREMISE - 通过微生物和免疫监测和流行病学的流行病应对存储库
批准号:
10710451
负责人:
CHRISTOPHER CASE
金额:
$100.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-04 至 2027-09-15

项目摘要

项目成果

CHRISTOPHER CASE的其他基金

相似基金

相关文献

中文摘要
翻译
VRC使命的关键组成部分之一是将有前途的疫苗和治疗候选物从实验室迅速推向临床。有必要支持转化研究,以确定治疗和预防传染病的新疗法或方法。PREMISE已被开发为通过微生物和 免疫监测和流行病学,并提供检测和监测新的和 新兴病原体和深层 在整个人群范围内分析宿主免疫反应,以便为有效应对传染病威胁做好准备。
英文摘要
One of the key components of the VRC mission involves the rapid advancement of promising vaccine and therapeutic candidates from the laboratory to the clinic. There is a need for supporting translational research leading to identification of new therapies or approaches in treating and preventing infectious diseases. PREMISE has been developed as a Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology, and provides detection and surveillance of novel and emerging pathogens and deep analysis of host immune responses at a population-wide scale in order to prepare for an effective response to infectious threats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology
  • 批准号:
    10722411
  • 项目类别:
  • 资助金额:
    $88.0万
  • 财政年份:
    2022
  • 负责人:
    CHRISTOPHER CASE
  • 依托单位:
NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents
  • 批准号:
    10722428
  • 项目类别:
  • 资助金额:
    $219.83万
  • 财政年份:
    2019
  • 负责人:
    CHRISTOPHER CASE
  • 依托单位:
TUBERCULOSIS VACCINE DEVELOPMENT
  • 批准号:
    9161858
  • 项目类别:
  • 资助金额:
    $200.0万
  • 财政年份:
    2015
  • 负责人:
    CHRISTOPHER CASE
  • 依托单位:
MALARIA VACCINE EVALUATION
  • 批准号:
    9161854
  • 项目类别:
  • 资助金额:
    $395.18万
  • 财政年份:
    2015
  • 负责人:
    CHRISTOPHER CASE
  • 依托单位:
海外基金